[1] JACK C R，BENNETT D A，BLENNOW K，et al.

NIA-AA Research Framework：Toward a biological

definition of Alzheimer's disease[J]. Alzheimers

Dement，2018，14（4）：535-562.

[2] WINBLAD B，AMOUYEL P，ANDRIEU S，et al.

Defeating Alzheimer's disease and other dementias：

a priority for European science and society[J].

Lancet Neurol，2016，15（5）：455-532.

[3] U.S. Department of Health and Human Services

Food and Drug Administration Center for Drug

Evaluation and Research（CDER）Center for

Biologics Evaluation and Research（CBER）.

Early Alzheimer's Disease：Developing Drugs for

Treatment-FDA[EB/OL]. [2018-01-29]（2018-07-

09）. http://www.fda.gov/downloads/Drugs/Guida

nceComplianceRegulatoryInformation/Guidances/

UCM596728.pdf.

[4] Alzheimer’s Association. 2017 Alzheimer’s Disease

Facts and Figures[J]. Alzheimer’s & Dementia，2017，

13（4）：325-373.

[5] HARDY J，SELKOE D J. The amyloid hypothesis of

Alzheimer's disease：progress and problems on the

road to therapeutics[J]. Science，2002，297（5580）：

353-356.

[6] MCKEITH I G，BOEVE B F，DICKSON D W，et

al. Diagnosis and management of dementia with

Lewy bodies：Fourth consensus report of the DLB